SIGA Technologies (NASDAQ:SIGA) was downgraded by investment analysts at TheStreet from an “a-” rating to a “c” rating in a note issued to investors on Tuesday, TheStreetRatingsTable reports.
Separately, Zacks Investment Research upgraded shares of SIGA Technologies from a “hold” rating to a “buy” rating and set a $10.00 price objective on the stock in a research note on Thursday.
NASDAQ:SIGA opened at $8.87 on Tuesday. SIGA Technologies has a fifty-two week low of $5.66 and a fifty-two week high of $9.82. The stock has a market capitalization of $657.41 million, a P/E ratio of 44.35 and a beta of 0.47. The company has a 50 day moving average price of $7.41 and a 200 day moving average price of $6.79.
About SIGA Technologies
SIGA Technologies, Inc is a commercial-stage pharmaceutical company which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses.
Featured Story: What is Call Option Volume?
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.